Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Context
Written by software from the filings listed below · Nov 19, 2026
What was filed. Bayer HealthCare LLC filed a SCHEDULE 13D/A on Nov 18, 2026 reporting 6,142,848 shares, 6.9% of the class of Senti Biosciences Holdings (SNTI) SEC Schedule 13D.
3 more points, with the facts they come from, are in OQRO Pro.
Senti Biosciences's L.P., Insider told the SEC about a plan to sell $319K of Senti Biosciences shares around Nov 20, 2026. The shares were not acquired as compensation. That is 0.1% of all Senti Biosciences shares.
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.